Atara Biotherapeutics Inc is a company in the U.S. stock market and it is a holding in 40 U.S.-traded ETFs. ATRA has around 5.1M shares in the U.S. ETF market. The largest ETF holder of ATRA is the SPDR S&P Biotech ETF (XBI), with approximately 1.60M shares. Investors may also find of interest that the ETF with the largest allocation to ATRA stock is Loncar Cancer Immunotherapy ETF (CNCR), with a portfolio weight of 2.19%. On average, U.S. ETFs allocate 0.12% of ATRA to their portfolios.
Additionally, ATRA is a favorite stock for Vanilla and Equal ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ATRA as a holding is the Principal Healthcare Innovators Index ETF (BTEC), with a return of 17.23%.